Electrophysiological and anatomical outcomes of subthreshold micropulse laser therapy in chronic central serous chorioretinopathy

Demir, Nur; Kayhan, Belma; Sevinçli, Şükrü; Sonmez, Murat

doi:10.1016/j.pdpdt.2022.103221

Cited by 2 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…So far, a relatively small number of studies reporting the application of the EpM system in CSCR have been published, so unequivocal conclusions are difficult to make. A recent study by Kayhan et al analyzed the efficacy of an EpM subthreshold laser in 18 chronic CSCR cases lasting for a mean of 12 months [40]. Significant improvements were noted with regard to CST, SRF volume, and multifocal electroretinogram parameters of the retina.…”

Section: End-point Managementmentioning

confidence: 99%

Laser Treatment of Central Serous Chorioretinopathy – An Update

Gawecki,

Pytrus,

Swiech

et al. 2024

Klin Monbl Augenheilkd

View full text Add to dashboard Cite

Laser treatment has been a mainstay for management of central serous chorioretinopathy for a few decades. Different types of lasers have been used and non-damaging retinal laser is the most recent option. The aim of this review is to provide an update on this form of treatment, based on the research published during last 5 years, in comparison with earlier studies published. A MEDLINE database search was performed with a combination of the following terms: central serous chorioretinopathy and laser photocoagulation or subthreshold laser or subthreshold micropulse laser or nanosecond laser or microsecond laser or end-point management or photodynamic therapy. Results were analyzed separately for each modality of laser treatment. Reports published in recent years confirm findings of previous research and do not distinguish treatments of this clinical entity. Among all analyzed laser options, photodynamic therapy provides the fastest and most prominent morphological improvements, including subretinal fluid resorption and reduction of choroidal thickness. This modality is also associated with fewer recurrences than with other treatments. Subthreshold micropulse laser allows the physician to maintain and, in selected cases, improve the patientʼs vision. Conventional photocoagulation is still effective, especially with the introduction of navigated laser systems. Despite the availability of variable laser treatment options, long-term functional improvements in chronic cases are minor for each modality. Long-lasting central serous chorioretinopathy cases with significantly altered retinal morphology do not usually present with functional improvement, despite satisfactory morphological outcomes. Early initiation of treatment has the potential to prevent visual loss and to improve the patientʼs quality of life.

show abstract

Section: End-point Managementmentioning

confidence: 99%